应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02511 君圣泰医药-B
开市前 05-03 09:04:33
5.400
+0.000
0.00%
最高
5.400
最低
5.400
成交量
0.00
今开
5.400
昨收
5.400
日振幅
0.00%
总市值
27.80亿
流通市值
27.80亿
总股本
5.15亿
成交额
0.00
换手率
0.00%
流通股本
5.15亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
君圣泰医药-B(02511)股价上升9.877%,现价港币$5.34
阿斯达克财经 · 05-02 10:15
君圣泰医药-B(02511)股价上升9.877%,现价港币$5.34
君圣泰医药-B(02511)股价大幅上升23.965%,现价港币$5.69
阿斯达克财经 · 04-18
君圣泰医药-B(02511)股价大幅上升23.965%,现价港币$5.69
君圣泰医药-B现涨近19% 已自主开发包含5款候选产品的产品管线
新浪港股 · 04-15
君圣泰医药-B现涨近19% 已自主开发包含5款候选产品的产品管线
港股异动 | 君圣泰医药-B(02511)一度涨超42% 此前宣布HTD1801的IIb期临床试验完成患者进组
智通财经 · 04-15
港股异动 | 君圣泰医药-B(02511)一度涨超42% 此前宣布HTD1801的IIb期临床试验完成患者进组
君圣泰医药-B大涨超44% 股价创约三周新高
市场资讯 · 04-15
君圣泰医药-B大涨超44% 股价创约三周新高
【港股通】君圣泰医药(02511)拉升逾40% 一度触发市调机制 此前HTD1801IIb期临床试验完成患者入组
金吾资讯 · 04-15
【港股通】君圣泰医药(02511)拉升逾40% 一度触发市调机制 此前HTD1801IIb期临床试验完成患者入组
君圣泰医药-B(02511)股价显著波动13.023%,现价港币$4.59
阿斯达克财经 · 04-15
君圣泰医药-B(02511)股价显著波动13.023%,现价港币$4.59
君圣泰医药-B(02511)股价下跌5.814%,现价港币$4.05
阿斯达克财经 · 04-15
君圣泰医药-B(02511)股价下跌5.814%,现价港币$4.05
君圣泰医药-B(02511)股价下跌5.109%,现价港币$5.2
阿斯达克财经 · 04-10
君圣泰医药-B(02511)股价下跌5.109%,现价港币$5.2
君圣泰医药-B(02511):HTD1801治疗代谢异常性脂肪性肝炎(MASH)IIb期的临床试验完成患者入组
智通财经 · 04-03
君圣泰医药-B(02511):HTD1801治疗代谢异常性脂肪性肝炎(MASH)IIb期的临床试验完成患者入组
君圣泰医药-B(02511.HK)HTD1801的IIb期临床试验完成患者入组
阿斯达克财经 · 04-03
君圣泰医药-B(02511.HK)HTD1801的IIb期临床试验完成患者入组
君圣泰医药-B(02511)发布年度业绩,研发成本3.12亿元,同比增长70.6%
智通财经 · 03-27
君圣泰医药-B(02511)发布年度业绩,研发成本3.12亿元,同比增长70.6%
《公司业绩》君圣泰医药-B(02511.HK)全年亏损扩大至9.39亿元人民币
阿斯达克财经 · 03-27
《公司业绩》君圣泰医药-B(02511.HK)全年亏损扩大至9.39亿元人民币
君圣泰医药-B03月27日获主力加仓234万元 环比增加3800.00%
自选股智能写手 · 03-27
君圣泰医药-B03月27日获主力加仓234万元 环比增加3800.00%
君圣泰医药-B(02511)股价下跌5.473%,现价港币$5.7
阿斯达克财经 · 03-27
君圣泰医药-B(02511)股价下跌5.473%,现价港币$5.7
君圣泰医药-B03月25日遭主力抛售57万元 环比增加5600.00%
自选股智能写手 · 03-25
君圣泰医药-B03月25日遭主力抛售57万元 环比增加5600.00%
君圣泰医药-B(02511)股价上升5.611%,现价港币$6.4
阿斯达克财经 · 03-25
君圣泰医药-B(02511)股价上升5.611%,现价港币$6.4
君圣泰医药-B03月22日主力资金流出1万元 连续3日减仓
自选股智能写手 · 03-22
君圣泰医药-B03月22日主力资金流出1万元 连续3日减仓
君圣泰医药-B(02511)股价下跌5.024%,现价港币$6.05
阿斯达克财经 · 03-20
君圣泰医药-B(02511)股价下跌5.024%,现价港币$6.05
君圣泰医药-B(02511)股价下跌5.618%,现价港币$7.56
阿斯达克财经 · 03-18
君圣泰医药-B(02511)股价下跌5.618%,现价港币$7.56
加载更多
公司概况
公司名称:
君圣泰医药-B
所属市场:
SEHK
上市日期:
--
主营业务:
HighTide Therapeutics Inc是一家主要从事原研药生产的公司。该公司专注于代谢疾病、消化系统疾病等领域。该公司开发针对非酒精性脂肪性肝炎(NASH)、2型糖尿病(T2DM)、严重高甘油三酯血症(SHTG)、原发性硬化性胆管炎(PSC)和原发性胆汁性胆管炎(PBC)等适应症的治疗方法。
发行价格:
--
{"stockData":{"symbol":"02511","market":"HK","secType":"STK","nameCN":"君圣泰医药-B","latestPrice":5.4,"timestamp":1714698026133,"preClose":5.4,"halted":0,"volume":0,"delay":0,"floatShares":514770668,"shares":514770668,"eps":-3.9267018,"marketStatus":"开市前","marketStatusCode":1,"change":0,"latestTime":"05-03 09:04:33","open":5.4,"high":5.4,"low":5.4,"amount":0,"amplitude":0,"askPrice":5.6,"askSize":1000,"bidPrice":5.35,"bidSize":8000,"shortable":0,"etf":0,"ttmEps":-3.926701860818056,"exchange":"SEHK","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714699800000},"adr":0,"listingDate":1703174400000,"adjPreClose":5.4,"openAndCloseTimeList":[[1714699800000,1714708800000],[1714712400000,1714723200000]],"volumeRatio":0,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02511","defaultTab":"news","newsList":[{"id":"2432699075","title":"君圣泰医药-B(02511)股价上升9.877%,现价港币$5.34","url":"https://stock-news.laohu8.com/highlight/detail?id=2432699075","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2432699075?lang=zh_cn&edition=full","pubTime":"2024-05-02 10:15","pubTimestamp":1714616100,"startTime":"0","endTime":"0","summary":"[上升股]君圣泰医药-B(02511) 股价在上午10:15比前收市价上升9.877%,现股价为港币$5.34。至目前为止,今日最高价为$5.34,而最低价为$4.87。总成交量为1.55万股,总成交金额为港币$7.956万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240502987/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428885965","title":"君圣泰医药-B(02511)股价大幅上升23.965%,现价港币$5.69","url":"https://stock-news.laohu8.com/highlight/detail?id=2428885965","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428885965?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:30","pubTimestamp":1713403800,"startTime":"0","endTime":"0","summary":"[上升股]君圣泰医药-B(02511) 股价在上午09:30比前收市价大幅上升23.965%,现股价为港币$5.69。至目前为止,今日最高价为$5.69,而最低价为$5.24。总成交量为9.95万股,总成交金额为港币$52.494万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR24041838/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427504066","title":"君圣泰医药-B现涨近19% 已自主开发包含5款候选产品的产品管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2427504066","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2427504066?lang=zh_cn&edition=full","pubTime":"2024-04-15 15:41","pubTimestamp":1713166863,"startTime":"0","endTime":"0","summary":"君圣泰医药-B(02511)午后一度涨超42%,涨幅现收窄至上涨18.61%,报5.10港元,成交额1372.642万港元。\n 据悉,君圣泰医药专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多靶点疗法。君圣泰医药已自主开发包含5款候选产品的产品管线,涵盖9种适应症,其中的5个适应症项目已处于临床开发阶段。除核心产品HTD1801外,其他还包括用于酒精性肝炎治疗的HTD4010 的早期临床开发、治疗肥胖症的HTD1804、治疗代谢疾病的HTD1805、治疗炎症性肠病的HTD2802等。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-15/doc-inarwyis6871461.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-15/doc-inarwyis6871461.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2427175042","title":"港股异动 | 君圣泰医药-B(02511)一度涨超42% 此前宣布HTD1801的IIb期临床试验完成患者进组","url":"https://stock-news.laohu8.com/highlight/detail?id=2427175042","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427175042?lang=zh_cn&edition=full","pubTime":"2024-04-15 14:57","pubTimestamp":1713164230,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,君圣泰医药-B一度涨超42%,截至发稿,涨23.49%,报5.31港元,成交额1238.88万港元。据悉,君圣泰医药专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多靶点疗法。君圣泰医药已自主开发包含5款候选产品的产品管线,涵盖9种适应症,其中的5个适应症项目已处于临床开发阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1102431.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427049195","title":"君圣泰医药-B大涨超44% 股价创约三周新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2427049195","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2427049195?lang=zh_cn&edition=full","pubTime":"2024-04-15 14:32","pubTimestamp":1713162727,"startTime":"0","endTime":"0","summary":"君圣泰医药-B午后逆势拉升,一度大涨超44%至6.2港元,一举收复4月以来失地,股价创3月26日以来约三周新高,市值约32亿港元。君圣泰医药4月初曾发公告称,公司自主研发的肠肝抗炎及代谢调节剂HTD1801的IIb期临床试验已完成患者入组,该试验针对伴有2型糖尿病或糖尿病前期的代谢异常性脂肪性肝炎患者。据悉,君圣泰于2011成立,专注于发现、开发及商业化多功能、多靶点的首创疗法以治疗代谢及消化系统疾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-15/doc-inarwyiw2624387.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-15/doc-inarwyiw2624387.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2427046162","title":"【港股通】君圣泰医药(02511)拉升逾40% 一度触发市调机制 此前HTD1801IIb期临床试验完成患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2427046162","media":"金吾资讯","top":-1,"share":"https://www.laohu8.com/m/news/2427046162?lang=zh_cn&edition=full","pubTime":"2024-04-15 14:05","pubTimestamp":1713161119,"startTime":"0","endTime":"0","summary":"金吾财讯 | 君圣泰医药(02511)午后短线拉升,并先后于13时48分、13时54分先后触发市调机制而进入冷静期,截至发稿,报6.03港元,涨40.23%,成交额838.87万港元。消息面上,此前公司自主研发的肠肝抗炎及代谢调节剂HTD1801(熊去氧胆小檗硷)的IIb期临床试验已完成患者入组,该试验针对伴有2型糖尿病(T2DM)或糖尿病前期的代谢异常性脂肪性肝炎(简称MASH,又称为非酒精性脂肪性肝炎,NASH)患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415140539877dffe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415140539877dffe1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427904331","title":"君圣泰医药-B(02511)股价显著波动13.023%,现价港币$4.59","url":"https://stock-news.laohu8.com/highlight/detail?id=2427904331","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427904331?lang=zh_cn&edition=full","pubTime":"2024-04-15 13:24","pubTimestamp":1713158640,"startTime":"0","endTime":"0","summary":"[异动股]君圣泰医药-B(02511) 股价在下午01:24出现显著波动13.023%,现股价为港币$4.59,比前收市价上升6.744%5.581%。至目前为止,今日最高价为$4.59,而最低价为$4.03。总成交量为30.45万股,总成交金额为港币$133.022万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150411171_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150411171_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAC24041551/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427201144","title":"君圣泰医药-B(02511)股价下跌5.814%,现价港币$4.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2427201144","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427201144?lang=zh_cn&edition=full","pubTime":"2024-04-15 11:34","pubTimestamp":1713152040,"startTime":"0","endTime":"0","summary":"[下跌股]君圣泰医药-B(02511) 股价在上午11:34比前收市价下跌5.814%,现股价为港币$4.05。至目前为止,今日最高价为$4.42,而最低价为$4.05。总成交量为11.05万股,总成交金额为港币$47.408万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404152096/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426310454","title":"君圣泰医药-B(02511)股价下跌5.109%,现价港币$5.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2426310454","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426310454?lang=zh_cn&edition=full","pubTime":"2024-04-10 14:42","pubTimestamp":1712731320,"startTime":"0","endTime":"0","summary":"[下跌股]君圣泰医药-B(02511) 股价在下午02:42比前收市价下跌5.109%,现股价为港币$5.2。至目前为止,今日最高价为$5.48,而最低价为$5.2。总成交量为12.35万股,总成交金额为港币$65.723万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404102762/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2424892244","title":"君圣泰医药-B(02511):HTD1801治疗代谢异常性脂肪性肝炎(MASH)IIb期的临床试验完成患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2424892244","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2424892244?lang=zh_cn&edition=full","pubTime":"2024-04-03 18:04","pubTimestamp":1712138694,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局于2018年11月授予HTD1801用于治疗代谢异常性脂肪性肝炎患者的快速通道资格认定。患有代谢异常性脂肪性肝炎及多种代谢异常的患者组织学恶化及全因死亡的风险更大。于早期的代谢异常性脂肪性肝炎IIa期试验中,HTD1801达到主要终点,18周治疗后肝脏脂肪含量显著减少。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1098504.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424006894","title":"君圣泰医药-B(02511.HK)HTD1801的IIb期临床试验完成患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2424006894","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2424006894?lang=zh_cn&edition=full","pubTime":"2024-04-03 17:58","pubTimestamp":1712138280,"startTime":"0","endTime":"0","summary":"君圣泰医药-B(02511.HK) 公布,自主研发的肠肝抗炎及代谢调节剂HTD1801(熊去氧胆小檗碱)的IIb期临床试验已完成患者入组,该试验针对伴有2型糖尿病(T2DM)或糖尿病前期的代谢异常性脂肪性肝炎患者。(sl/u)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20240109103803994_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20240109103803994_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1340008/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2422163960","title":"君圣泰医药-B(02511)发布年度业绩,研发成本3.12亿元,同比增长70.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422163960","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422163960?lang=zh_cn&edition=full","pubTime":"2024-03-27 19:00","pubTimestamp":1711537256,"startTime":"0","endTime":"0","summary":"据悉,该公司为一间生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多靶点疗法。公司已自主开发包含5款候选产品的产品管线,涵盖代谢及消化系统疾病的9种适应症,其中5种适应症处于临床阶段。公司致力于开发多功能及多靶点疗法,以系统性的方法治疗复杂的代谢及消化系统疾病,为患者提供有效及安全的治疗选择,以改善患者的整体临床获益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271925168b698531&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271925168b698531&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422896424","title":"《公司业绩》君圣泰医药-B(02511.HK)全年亏损扩大至9.39亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2422896424","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422896424?lang=zh_cn&edition=full","pubTime":"2024-03-27 18:56","pubTimestamp":1711536960,"startTime":"0","endTime":"0","summary":"君圣泰医药-B(02511.HK) 公布截至去年12月底止全年业绩,其他收入及收益3,421.4万元人民币(下同),按年升66.2%。亏损扩大至9.39亿元,上年同期蚀1.9亿元;每股亏损3.62元。不派息。(su/a)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20240109103803994_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20240109103803994_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1337791/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2422395919","title":"君圣泰医药-B03月27日获主力加仓234万元 环比增加3800.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422395919","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422395919?lang=zh_cn&edition=full","pubTime":"2024-03-27 16:16","pubTimestamp":1711527364,"startTime":"0","endTime":"0","summary":"03月27日, 君圣泰医药-B股价跌5.80%,报收5.68元,成交金额463万元,换手率0.16%,振幅6.14%,量比1.03。君圣泰医药-B今日主力资金净流入234万元,上一交易日主力净流入6万元,今日环比增加3800.00%。该股近5个交易日下跌6.58%,主力资金累计净流入148万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入869万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032716163487bb720b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032716163487bb720b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422986140","title":"君圣泰医药-B(02511)股价下跌5.473%,现价港币$5.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2422986140","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422986140?lang=zh_cn&edition=full","pubTime":"2024-03-27 11:09","pubTimestamp":1711508940,"startTime":"0","endTime":"0","summary":"[下跌股]君圣泰医药-B(02511) 股价在上午11:09比前收市价下跌5.473%,现股价为港币$5.7。至目前为止,今日最高价为$6.05,而最低价为$5.7。总成交量为14.15万股,总成交金额为港币$83.529万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403271630/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2422562378","title":"君圣泰医药-B03月25日遭主力抛售57万元 环比增加5600.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422562378","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422562378?lang=zh_cn&edition=full","pubTime":"2024-03-25 16:17","pubTimestamp":1711354622,"startTime":"0","endTime":"0","summary":"03月25日,君圣泰医药-B股价收平报6.06元,成交金额602万元,换手率0.19%,振幅9.74%,量比1.18。君圣泰医药-B今日主力资金净流出57万元,连续4日净流出,上一交易日主力净流出1万元,今日环比增加5600.00%。该股近5个交易日下跌21.09%,主力资金累计净流出123万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入628万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251618068b6034bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251618068b6034bf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422539405","title":"君圣泰医药-B(02511)股价上升5.611%,现价港币$6.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2422539405","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422539405?lang=zh_cn&edition=full","pubTime":"2024-03-25 10:23","pubTimestamp":1711333380,"startTime":"0","endTime":"0","summary":"[上升股]君圣泰医药-B(02511) 股价在上午10:23比前收市价上升5.611%,现股价为港币$6.4。至目前为止,今日最高价为$6.4,而最低价为$6.09。总成交量为24.65万股,总成交金额为港币$153.075万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2403251013/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2421865620","title":"君圣泰医药-B03月22日主力资金流出1万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2421865620","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421865620?lang=zh_cn&edition=full","pubTime":"2024-03-22 16:16","pubTimestamp":1711095372,"startTime":"0","endTime":"0","summary":"03月22日, 君圣泰医药-B股价跌0.49%,报收6.06元,成交金额1084万元,换手率0.33%,振幅19.38%,量比2.38。君圣泰医药-B今日主力资金净流出1万元,连续3日净流出,上一交易日主力净流出36万元,今日环比减少97.22%。该股近5个交易日下跌23.85%,主力资金累计净流出66万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流入684万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032216165687a6200b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032216165687a6200b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420760531","title":"君圣泰医药-B(02511)股价下跌5.024%,现价港币$6.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2420760531","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2420760531?lang=zh_cn&edition=full","pubTime":"2024-03-20 14:37","pubTimestamp":1710916620,"startTime":"0","endTime":"0","summary":"[下跌股]君圣泰医药-B(02511) 股价在下午02:37比前收市价下跌5.024%,现股价为港币$6.05。至目前为止,今日最高价为$6.5,而最低价为$6.05。总成交量为25.5万股,总成交金额为港币$159.852万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403201069/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2420446694","title":"君圣泰医药-B(02511)股价下跌5.618%,现价港币$7.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2420446694","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2420446694?lang=zh_cn&edition=full","pubTime":"2024-03-18 15:42","pubTimestamp":1710747720,"startTime":"0","endTime":"0","summary":"[下跌股]君圣泰医药-B(02511) 股价在下午03:42比前收市价下跌5.618%,现股价为港币$7.56。至目前为止,今日最高价为$8.1,而最低价为$7.56。总成交量为13.95万股,总成交金额为港币$108.648万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403181302/aamm-all-category","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hightidetx.com","stockEarnings":[{"period":"1week","weight":0.08},{"period":"1month","weight":-0.0459},{"period":"3month","weight":-0.5408},{"period":"6month","weight":-0.5304},{"period":"ytd","weight":-0.5833}],"compareEarnings":[{"period":"1week","weight":0.0534},{"period":"1month","weight":0.0753},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0307},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":0.068}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"HighTide Therapeutics Inc是一家主要从事原研药生产的公司。该公司专注于代谢疾病、消化系统疾病等领域。该公司开发针对非酒精性脂肪性肝炎(NASH)、2型糖尿病(T2DM)、严重高甘油三酯血症(SHTG)、原发性硬化性胆管炎(PSC)和原发性胆汁性胆管炎(PBC)等适应症的治疗方法。","exchange":"SEHK","name":"君圣泰医药-B","nameEN":"HIGHTIDE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君圣泰医药-B(02511)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君圣泰医药-B(02511)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君圣泰医药-B,02511,君圣泰医药-B股票,君圣泰医药-B股票老虎,君圣泰医药-B股票老虎国际,君圣泰医药-B行情,君圣泰医药-B股票行情,君圣泰医药-B股价,君圣泰医药-B股市,君圣泰医药-B股票价格,君圣泰医药-B股票交易,君圣泰医药-B股票购买,君圣泰医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君圣泰医药-B(02511)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君圣泰医药-B(02511)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}